News Image

Context Therapeutics Appoints Chief Medical Officer and Vice President of Clinical Operations

Provided By GlobeNewswire

Last update: Aug 1, 2024

Company announces appointments of Dr. Claudio Dansky Ullmann as CMO and Ms. Karen Andreas as VP, Clinical Operations

Appointments support the development of the Company’s two clinical-stage T cell engaging assets to treat solid tumors

Read more at globenewswire.com

CONTEXT THERAPEUTICS INC

NASDAQ:CNTX (12/15/2025, 6:44:50 PM)

After market: 1.1 -0.03 (-2.65%)

1.13

+0.09 (+8.65%)



Find more stocks in the Stock Screener

Follow ChartMill for more